Amerikanische Gesellschaft für Hirudotherapie

Acute postoperative infection with Aeromonas hydrophila after using medical leeches for treatment of venous congestion

Case series published in Archives of Orthopaedic and Trauma Surgery (2010)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportSicherheit & InfektionskontrolleKlinische StudienSchnabl SM, Kunz C, Unglaub F et al. · Archives of orthopaedic and trauma surgery, 2010

Abstract

INTRODUCTION: Venous convulsion after reconstructive microsurgery procedures is one major complication a surgeon has to deal with. Today, especially in the field of reconstructive microsurgery, medicinal leech therapy enjoys a renaissance. The potential risks such as infections associated with leech therapy are generally underestimated and not sufficiently discussed in literature. METHOD/PATIENTS: We present five male patients with an average age of 47 years. All patients suffered from a trauma incident, which had to be treated as an emergency. Three patients showed, postoperatively, a venous congestion after the reconstructive procedures. Another two patients with flap reconstruction and flap training developed venous problems after 12 and 14 days. In all five cases, the indication was given to use medical leeches (Hirudo medicinalis). In all the patients, a local infection of the injured extremity could be regarded after beginning with the leech treatment. The treatment duration with medical leeches for postoperative venous congestion was an average of 6 days. RESULTS: The reconstructive procedures in all five cases were unfortunately unsuccessful as major local infections were observed. Microbiological analyses showed, in all cases, an infection with Aeromonas hydrophila. CONCLUSION: We recommend making a considered indication for leech therapy, to diagnose wound infections early and to think about prophylactic antibiotics in patients with leech application.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAeromonas hydrophilaAnimalsGram-Negative Bacterial InfectionsHirudo medicinalisHumansLeechingMaleMicrosurgeryMiddle AgedPlastic Surgery ProceduresSurgical FlapsTreatment Failure

Zusammenfassung

Five patients receiving leech therapy after reconstructive microsurgery developed Aeromonas hydrophila infections leading to flap failure, underscoring the importance of antibiotic prophylaxis and early infection diagnosis.

Warum dies für die Hirudotherapie relevant ist

This report describes five male trauma patients who developed local infections with Aeromonas hydrophila following medical leech (Hirudo medicinalis) therapy for postoperative venous congestion after reconstructive microsurgery procedures. The findings are directly relevant to hirudotherapy practice, as all five reconstructive procedures were unsuccessful due to major local infections, leading the authors to recommend careful indication for leech therapy, early diagnosis of wound infections, and consideration of prophylactic antibiotics when leeches are applied. However, the report involves only five patients and the abstract provides limited detail on microbiological methodology, whether antibiotic prophylaxis was used initially, or comparative infection rates, restricting broader conclusions about infection risk magnitude or optimal prevention strategies.

Zitation

Acute postoperative infection with Aeromonas hydrophila after using medical leeches for treatment of venous congestion.

Schnabl SM, Kunz C, Unglaub F et al. · Archives of orthopaedic and trauma surgery, 2010

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.